A recent clinical trial has unveiled promising data for a novel approach to cancer treatment, leveraging the Parsortix system to identify patients with highly metastatic...
Clinical Trial
TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company specializing in allogeneic gamma-delta T cell therapies, has made notable progress in its ACHIEVE Phase...
